Clinical Trial Update: Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and preliminary efficacy of combining axicabtagene ciloleucel with utomilumab in adults with relapsed/refractory large B-cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• Axicabtagene ciloleucel (axicabtagene ciloleucel)
• Utomilumab (utomilumab)

Snippet

Sponsor: Kite, A Gilead Company | Conditions: Relapsed/Refractory Large B-cell Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2024-06-28